NewAmsterdam Pharma Company N.V (NAMS) Margins & Profitability 2023-2026
Gross, EBITDA, operating, and net margin trends
Margins
Profit margins across the income statement
- EBITDA Margin
- -1751.0%
- Op. Margin
- -1752.6% 841.6%
- Net Margin
- -1732.9% 1810.7%
Gross Margin (%)
Revenue left after direct cost of goods sold
EBITDA Margin (%)
Operating profitability independent of capital structure
Operating & Net Margins (%)
How much of each dollar becomes profit